Joshua F. Patterson serves as General Counsel, Chief Compliance Officer, and Secretary at CG Oncology Inc., a clinical-stage biotechnology company dedicated to developing innovative therapies for urothelial cancer. In this critical leadership role, he oversees all legal, compliance, and corporate secretarial functions, providing strategic counsel on regulatory matters, intellectual property, corporate governance, and risk management. His expertise has been instrumental in guiding the company through pivotal milestones, including its preparation for an initial public offering and navigation of complex FDA interactions. With over 20 years of experience in the life sciences industry, Mr. Patterson brings a proven track record of success in high-stakes legal environments. Prior to joining CG Oncology in 2021, he held senior legal positions at leading biotechnology firms, including serving as Vice President, Legal at a clinical-stage oncology company where he spearheaded legal strategies for multiple Phase III trials, strategic partnerships, and a successful Series D financing round exceeding $200 million. Earlier in his career, he was a partner at a premier life sciences law firm, advising on mergers and acquisitions, licensing agreements, and securities offerings valued in the billions. Mr. Patterson's achievements include securing key patent portfolios that protect groundbreaking oncolytic immunotherapies and fostering compliance programs that have earned accolades for excellence in healthcare governance. A graduate of the University of California, Berkeley School of Law (J.D.) and Stanford University (B.A.), he is licensed to practice in California and actively contributes to industry organizations focused on biotech ethics and innovation.